semaglutide pancreas cancer Semaglutide: What we know about safety and risk GLP-1 Pancreatic Cancer Risk: What

Approvals in metabolic liver disease and cardiovascular risk reduction reinforce their role as cardiometabolic therapies

The prospect of unexpected pregnancy is both delightful for those who have struggled with their fertility and longed for a baby and extremely troubling, for those who don't want kids

In comparison to sulfonylureas, GLP-1RA use was linked to a lower risk of 23 outcomes, including bronchitis, pneumonia, suicidal ideation, chronic obstructive pulmonary disease (COPD), and coagulopathy, and an increased risk of 14 outcomes, including gastroesophageal reflux disease (GERD) nausea, vomiting, sleep disturbances, abdominal pain, and bone pain

If a compounded product is significantly cheaper but delivers inconsistent potency, the savings evaporate alongside the results

Elevated levels of circulating biomarkers related to leaky gut syndrome and bacterial translocation are associated with Graves disease